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Abstract: A new class of water-soluble C60 transfecting agents has been prepared using
Hirsch-Bingel chemistry and assessed for their ability to act as gene-delivery vectors in vitro.
In an effort to elucidate the relationship between the hydrophobicity of the fullerene core, the
hydrophilicity of the water-solubilizing groups, and the overall charge state of the C60 vectors in
gene delivery and expression, several different C60 derivatives were synthesized to yield either
positively charged, negatively charged, or neutral chemical functionalities under physiological
conditions. These fullerene derivatives were then tested for their ability to transfect cells grown
in culture with DNA carrying the green ﬂuorescent protein (GFP) reporter gene. Statistically
signiﬁcant expression of GFP was observed for all forms of the C60 derivatives when used as
DNA vectors and compared to the ability of naked DNA alone to transfect cells. However, efﬁcient
in vitro transfection was only achieved with the two positively charged C60 derivatives, namely,
an octa-amino derivatized C60 and a dodeca-amino derivatized C60 vector. All C60 vectors showed
an increase in toxicity in a dose-dependent manner. Increased levels of cellular toxicity were
observed for positively charged C60 vectors relative to the negatively charged and neutral vectors.
Structural analyses using dynamic light scattering and optical microscopy offered further insights
into possible correlations between the various derivatized C60 compounds, the C60 vector/DNA
complexes, their physical attributes (aggregation, charge) and their transfection efﬁciencies.
Recently, similar Gd@C60-based compounds have demonstrated potential as advanced contrast
agents for magnetic resonance imaging (MRI). Thus, the successful demonstration of intracellular
DNA uptake, intracellular transport, and gene expression from DNA using C60 vectors suggests
the possibility of developing analogous Gd@C60-based vectors to serve simultaneously as both
therapeutic and diagnostic agents.
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Introduction
Delivery of exogenous nucleic acids such as DNA into
cells (transfection) holds great promise for disease prevention
and therapy (aka: gene therapy).
1 Genetic material delivered
into the cell modiﬁes the function of such cells generally by
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Published on Web 05/28/2008altering the production of proteins. The selection of ap-
propriate DNA carriers is a common problem for gene
therapy, and better gene delivery agents are still being sought.
Viral vectors (such as retroviral, lentiviral, adenoviral) and
nonviral vectors (such as liposomal and polymeric) have both
been used as gene delivery agents in the past. Although viral
vectors are efﬁcient carriers due to their natural ability to
penetrate cells, they have also often been shown to provoke
undesirable immune responses, thus limiting their useful-
ness.
2 Nonviral vectors often prove less immunogenic, but
improvement is needed to increase their overall transfection
efﬁciency. To increase such efﬁciency, effort should be
directed at increasing the vector’s ability to promote efﬁcient
DNA condensation, intracellular transport, and sustained gene
expression. Additionally, the cytocompatibility of nonviral
vectors must be well understood before they can be further
optimized and become a viable option for gene therapy.
3–7
Fullerene (C60) derivatives have been extensively studied
for a variety of medical applications
8 including their use as
neuroprotective agents,
9 HIV-1 protease inhibitors,
10 bone-
disorder therapy agents,
11 X-ray contrast agents,
12 and slow-
release agents for drug delivery.
13 Recently, C60-based
reagents have also been examined as DNA transfection
vectors and tested for the ability to mediate gene transfer.
14–18
These ﬁrst generation C60-based transfection vectors have
shown promise, but a few have also exhibited high cyto-
toxicity.
16 As many of the C60 derivatives previously
described in the literature have only been slightly soluble in
aqueous solutions, it has also been suggested that one
possible reason for such observed cytotoxicity was due to
the use of organic solvents that were necessary to dissolve
those ﬁrst generation C60-based transfection agents.
14,16 Thus,
the search for new materials and enhanced protocols are key
objectives in the continuing development of C60-based
transfection vectors, including the design, construction, and
testing of new reagents that are water soluble and able to
effect enhanced gene delivery without promoting signiﬁcant
cytotoxicity.
Herein we report transfection efﬁciencies, cytotoxicity
proﬁles, and biophysical structure/activity studies for a new
class of water-soluble C60 vectors prepared using the
Hirsch-Bingel reaction
19,20 which is one of the simplest,
highest-yielding, and most versatile C60 functionalization
methods known. As shown in Figure 1, the structurally
(1) Lodish, H.; Berk, A.; Zipursky, S. L.; Matsudaira, P.; Balimore,
D.; Darnell, J. Molecular Cell Biology; 5th ed.; W. H. Freeman
& Co.: New York, 2000.
(2) Worgall, S.; Wolff, G.; Falck Pedersen, E.; Crystal, R. Innate
Immune Mechanisms Dominate Elimination of Adenovirus Vec-
tors Following In Vivo Administration. Hum. Gene Ther. 1997,
8, 37–44.
(3) Verma, I.; Somia, N. Gene Therapy - Promises, Problems and
Prospects. Nature 1997, 389, 239–242.
(4) Godbey, W. T.; Mikos, A. G. Recent Progress in Gene Delivery
Using Non-Viral Transfer Complexes. J. Controlled Release 2001,
72, 115–125.
(5) Neu, M.; Fischer, D.; Kissel, T. Recent Advances in Rational Gene
Transfer Vector Design Based on Poly(ethylene imine) and Its
Derivatives. J. Gene Med. 2005, 7, 992–1009.
(6) Miller, A. D. The Problem with Cationic Liposome/Micelle-Based
Non-Viral Vector Systems for Gene Therapy. Current Medicinal
Chemistry 2003, 10 (14), 1195.
(7) Lv, H.; Zhang, S.; Wang, B.; Cui, S.; Yan, J. Toxicity of Cationic
Lipids and Cationic Polymers in Gene Delivery. J. Controlled
Release 2006, 114 (1), 100.
(8) Nakamura, E.; Isobe, H. Functionalized Fullerenes in Water. The
First 10 Years of Their Chemistry, Biology, and Nanoscience.
Acc. Chem. Res. 2003, 36, 807–815.
(9) Dugan, L. L.; Turetsky, D. M.; Du, C.; Lobner, D.; Wheeler, M.;
Almli, C. R.; Shen, C.; Luh, T.; Choi, D.; Lin, T. Carboxy-
fullerenes as Neuroprotective Antioxidants. Proc. Natl. Acad. Sci.
U.S.A. 1997, 94, 9434–9439.
(10) Friedman, S. H.; DeCamp, D. L.; Sijbesma, R. P.; Srdanov, G.;
Wudl, F.; Kenyon, G. L. J. Am. Chem. Soc. 1993, 115, 6506.
(11) Mirakyan, A. L.; Wilson, L. J. Functionalization of C60 with
Bisphosphonate Groups: A Route to Bone-Vectored Fullerenes.
J. Chem. Soc., Perkin Trans. 2002, 2, 1173–1176.
(12) Wharton, T.; J., W. L. Highly-Iodinated Fullereneas a Contrast
Agent for X-Ray Imaging. Bioorg. Med. Chem. 2002, 10, 3545–
3554.
(13) Zakharian, T. Y.; Seryshev, A.; Sitharaman, B.; Gilbert, B. E.;
Knight, V.; Wilson, L. J. A Fullerene-Paclitaxel Chemotherapeu-
tic: Synthesis, Characterization, and Biological Activity in Tissue
Culture. J. Am. Chem. Soc. 2005, 27, 12508–12509.
(14) Nakamura, E.; Isobe, H.; Tomita, N.; Sawamura, M.; Jinno, S.;
Okayama, H. Functionalized Fullerene as an Artiﬁcial Vector for
Transfection. Angew. Chem., Int. Ed. 2000, 39, 4254–4257.
Figure 1. Depiction of the structures of the derivatized C60 vectors; the positively charged amino-C60 compounds
(I-IV), the neutral serinolamide-C60 compound (V), and the negatively charged C3-C60 compound (VI) (chemical
structures depicted at neutral pH in aqueous solution; counterions in solution not shown).
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yield either positively charged, negatively charged, or neutral
chemical structures when solvated under physiological
conditions. These vectors, which have been analyzed for their
ability to promote DNA transfection, offer the opportunity
to elucidate the roles that hydrophobicity (due to the fullerene
core), hydrophilicity (due to the water soluble substituents),
and overall charge state displayed by the C60 derivatives have
on DNA transfection, gene expression, and cytotoxicity.
Experimental Section
Materials. All compounds were reagent grade or better.
C60 was purchased from MER Corporation (Tucson, AZ).
All solvents were HPLC grade purchased from Fisher
(Pittsburgh, PA). Materials for culturing cells, including
Dulbecco’s modiﬁed Eagle’s medium (DMEM), trypsin, and
phosphate buffer saline (PBS), were obtained from Gibco
(Gibco Life, Grand Island, NY). Complete osteogenic
medium containing minimum essential medium (MEM), 10
mM  -glycerophosphate, 50 µg/mL ascorbic acid, and 10
vol % fetal bovine serum was obtained from Gemini Bio-
Products (Calabasas, CA). Cytopure was purchased from
Q-Biogene (Solon, OH). A plasmid DNA (7.2 kbp) contain-
ing the gene for a red-shifted wavelength variant of the
enhanced green ﬂuorescent protein (eGFP) under the tran-
scriptional control of the cytomegalovirus (CMV) immediate-
early gene promoter was used as the DNA construct from
which reporter gene expression was measured in the trans-
fection assays. Plasmid DNA was prepared in bulk from
transformed bacterial sources and puriﬁed to homogeneity
using commercial kits (Qiagen; Germantown, MD) employ-
ing anion-exchange chromatography.
C60 Sample Preparation. The amino-C60 adducts (I-IV),
the seri-C60 adduct (V), and the C3-C60 adduct (VI) were
synthesized and characterized according to previously pub-
lished procedures.
21–23 Compounds I-V were mixtures of
regioisomers.
Stock solutions of individual compounds I-VI were
prepared by weight and ﬁltered for sterilization using a
cellulose acetate membrane ﬁlter (0.2 µm pore diameter)
prior to use in forming transfection mixtures. Standard
solutions were prepared at a concentration 10 µg/µL for each
of these compounds in both tris EDTA (TE) solution (10
mM tris, 1 mM EDTA, pH ) 7.4), and in serum-free DMEM
in separate reaction vials.
Cell Culture. NIH 3T3 mouse ﬁbroblast cells (ATCC #
CRL-1658) and HEK 293 cells (human embryonic kidney;
ATCC # CRL-1573) were cultured in DMEM containing
10% FBS in a 5% CO2 atmosphere at 37 °C prior to
collection and plating in individual assay wells used for
transfection studies. For subculture of cells, routinely on
reaching 80% conﬂuence, the cells were washed with PBS,
detached using trypsin-EDTA, harvested by centrifugation,
resuspended in culture medium and counted in a Coulter
counter prior to plating in multiwell dishes for subsequent
transfection assays. Marrow stromal cells (MSCs) were
harvested from Wistar rats as previously described.
24 MSCs
were cultured for 6 days in the presence of 10
-8 M
dexamethasone in complete osteogenic media before use in
transfection studies and cultured under identical environ-
mental conditions to 3T3 and HEK 293 cells.
Preparation of Solutions for the Transfection Studies.
Mixtures of individual derivatized C60 vector material and
plasmid DNA were allowed to form a complex in serum-
free DMEM, as described below, prior to adding to cells in
the transfection assays. Each C60-vector solution was added
dropwise to a solution of plasmid DNA to obtain a ﬁnal
volume of 200 µL. Each resulting solution was then vortexed
brieﬂy and allowed to stand for 30 min at room temperature
to allow complete assembly of the vector/DNA complex,
which was then used immediately in the transfection experi-
ment. The ﬁnal DNA mass of each solution remained
constant at 10 µg while the concentration of the C60 derivative
was varied to obtain a range of C60-reagent-to-DNA-base-
pair (bp) ratios (deﬁned here as “R” values). The value of
DNA mass was ﬁxed at 10 µg per well since it showed the
most optimum transfection among different DNA masses
used (1-12 µg) for transfection at R ) 16.8. Each solution
was prepared in triplicate.
(15) Isobe, H.; Tomita, N.; Jinno, S.; Okayama, H.; Nakamura, E.
Synthesis and Transfection Capability of Multi-Functionalized
Fullerene Polyamine. Chem. Lett. 2001, 1214, 1215.
(16) Isobe, H.; Nakanishi, W.; Tomita, N.; Jinno, S.; Okayama, H.;
Nakamura, E. Nonviral Gene Delivery by Tetraamino Fullerene.
Mol. Pharmaceutics 2006, 3, 124–134.
(17) Isobe, H.; Nakanishi, W.; Tomita, N.; Jinno, S.; Okayama, H.;
Nakamura, E. Gene Delivery by Aminofullerenes: Structural
Requirements for Efﬁcient Transfection. ChemistrysAsian J.
2006, 1, 167–175.
(18) Klumpp, C.; Lacerda, L.; Chaloin, O.; Ros, T. D.; Kostarelos,
K.; Prato, M.; Bianco, A. Multifunctionalised cationic fullerene
adducts for gene transfer: design, synthesis and DNA complex-
ation. Chem. Commun. 2007, 3762.
(19) Bingel, C. Cyclopropanierung Von Fullerenen. Chem. Ber. 1993,
126, 1957.
(20) Hirsch, A.; Lamparth, I.; Karfunkel, H. R. Fullerene Chemistry
in Three Dimensions: Isolation of Seven Regioisomeric Bisadducts
and Chiral Trisadducts of C60 and Di(ethoxycarbonyl)methylene.
Angew. Chem., Int. Ed. 1994, 33, 437.
(21) Richardson, C. F.; Schuster, D. I.; Wilson, S. R. Synthesis and
Characterization of Water-Soluble Amino Fullerene Derivatives.
Org. Lett. 2000, 2, 1011–1014.
(22) Lamparth, I.; Hirsch, A. Water-Soluble Malonic Acid Derivatives
of C60 with a Deﬁned Three-Dimensional Structure. J. Chem. Soc.
Chem. Commun. 1994, 1727.
(23) Wharton, T.; Kini, V. U.; Mortis, R. A.; Wilson, L. J. New Non-
Ionic, Highly Water-Soluble Derivatives of C60 Designed for
Biological Compatibility. Tetrahedron Lett. 2001, 42, 5159–5162.
(24) Datta, N.; P., Q. P. P. Q.; Sharma, U.; Sikavitsas, V. I.; Jansen,
J. A.; Mikos, A. G. In Vitro Generated Extracellular Matrix and
Fluid Shear Stress Synergistically Snhance 3D Osteoblastic
Differentiation. Proceed. Natl. Acad. Sci. U.S.A. 2006, 103, 2488–
2493.
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and MSCs were used for transfection studies. Transfections
of NIH 3T3 cells were carried out with C60/DNA complexes
in a range of R values (0.42-42). For HEK 293 cells and
MSCs, transfections were performed only at R ) 4.2 and R
) 16.8. Cells were plated at 40,000 cells/cm
2 in 96 well
tissue culture plates and incubated overnight to permit cell
attachment to the well surface. The culture medium was then
replaced by the serum-free transfection mixture for various
time periods (2 h, 8 h, 24 or 48 h) (transfection time). After
exposing the cells for the respective periods of time to the
serum-free transfection mixture, the cells were washed with
PBS and the medium was replaced with complete medium
(containing FBS). The cells were then further incubated for
8 h, 24 or 48 h (incubation time) before GFP ﬂuorescence
was measured using a ﬂow cytometer. For comparative
purposes, control cell populations were also transfected with
plasmid DNA alone (no C60 vector), or with plasmid DNA
complexed with an optimal level of one of two commercially
available transfection reagents; such that the DNA was
complexed with either 25 kDa polyethylenimine (PEI), or
with Cytopure transfection reagent, which is reported by the
manufacturer to exhibit very low levels of cytotoxicity. The
DNA/PEI complexes were assembled using a well-estab-
lished protocol
25 and the cytopure/DNA complexes were
assembled as per the manufacturer’s instructions and opti-
mized to obtain an optimal level of DNA transfection/GFP
expression within the NIH 3T3 cell type. Below is a brief
description of the conditions which gave the optimal level
of transfected NIH 3T3 cells using 25 kDa PEI and Cytopure.
For PEI, the polymer was dissolved in PBS as 1 mg/mL
stock solution. DNA/polymer complexes were prepared in
serum-free DMEM to achieve a ratio of polymer to DNA of
4. The complexes (100 µL) were then incubated at 25 °C
for 10-15 min and then added to cell wells that contained
100 µL of serum-free DMEM. For Cytopure, 1.1 µLo f
Cytopure stock was diluted to 50 µL with serum-free
DMEM. The Cytopure mixture was then added slowly to 1
µg of DNA diluted to 50 µL with serum-free DMEM. The
transfection mixture was vortexed, left standing for 15 min
at room temperature and added to cell wells that contained
100 µL of serum-free DMEM. After 24 h of transfection,
the cells were washed and the medium was replaced with
the serum-containing medium.
For purposes of this study, a “positive transfection” result
was deﬁned to be “expression of GFP”, not simply plasmid
DNA uptake into cells. As such, successful “transfection”
as described herein also relates to cell viability for sufﬁcient
time to ensure GFP gene expression, which was determined
by cell ﬂuorescence levels above a deﬁned background
threshold level (determined using nontransfected cells to set
lower detection limit parameter) with ﬂow cytometry. Cells
were prepared for ﬂow cytometry by trypsinization after
being washed with sterile PBS to remove cell debris and
any residual gene-delivery agents. Cells were then analyzed
using ﬂow cytometry (Beckmann-Coulter). Cells that were
transfected successfully expressed GFP protein and were
detected at 470/515 nm (excitation/emission) by the ﬂow
cytometer.
Transfection efﬁciency has been determined as the percent
of cells that express GFP per study sample relative to the
total number of cells passing through the ﬂow cytometer per
study sample (10,000 events counted for each transfection
sample).
25
Preparation of Solutions for Cytotoxicity Studies. The
C60/DNA complex solutions were prepared as described
above. C60 vector solutions without DNA (0-10 µg/µL) were
prepared by diluting the C60 stock solution with serum-free
DMEM.
Cytotoxicity Experiments. All cytotoxicity studies were
performed on NIH 3T3 cells. The concentration of cultured
cells was determined prior to cell plating using a Coulter
counter and the cells were plated on 96 well clear-bottom
plates at a density of 40,000 cells/cm
2. After incubating
overnight to allow cell attachment, the medium in each well
was replaced either with 200 µL of the C60 vector alone or
with C60 vector/DNA solutions prepared as described above.
The cells were exposed to the solutions for either 2, 8 or
24 h before the cytotoxicity was determined. Control cell
samples were plated and grown under identical conditions
as those described for treated cell samples, with the exception
that neither C60 compounds nor transfection mixtures were
added to the control cells. All transfection and control
experiments were performed and analyzed in triplicate as
described below.
The LIVE/DEAD viability/cytotoxicity assay (Molecular
probes, Eugene, OR) was used to determine cytotoxicity
levels in cells treated with either C60-vector or C60-vector/
DNA solutions. This assay makes use of 2 different
ﬂuorescent dyes, calcein AM and ethidium homodimer
(EThD-1), to measure the number of live and dead cells
respectively. The lipid permeable dye, calcein AM, when
taken up by living cells with intact plasma membranes, emits
green ﬂuorescence (excitation/emission: 495/515 nm) upon
being cleaved by esterase enzymes in the cells. Conversely,
the EThD-1 dye emits red ﬂuorescence (excitation/emission:
528/617 nm) on binding to nucleic acids released from dead
cells, and is excluded by the intact cell membranes of viable
cells. This assay was preferred over the 3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for
evaluation of cell viability because C60-vectors compounds
I and II interacted and attached to the MTT-formazan making
the formazan crystals insoluble for the next colorimetric
assay. Similar effects have been reported for single-walled
carbon nanotubes.
26 The reagents were prepared and added
to the wells according to the manufacturer’s guidelines. At
(25) Godbey, W. T.; Wu, K. K.; Hirasaki, G. J.; Mikos, A. G. Improved
Packing of Poly(ethylenimine)/DNA Complexes Increases Trans-
fection Efﬁciency WT. Gene Ther. 1999, 6, 1380–1388.
(26) Wo ¨rle-Knirsch, J. M.; Pulskamp, K.; Krug, H. F. Oops they did
it again! Carbon nanotubes hoax scientists in viability assays. Nano
Lett. 2006, 6, 1261–1268.
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aspirated and replaced with the LIVE/DEAD reagent, after
washing the cells with PBS. The plates were then incubated
in the dark at room temperature for additional 30 min before
being measured for ﬂuorescence.
Fluorescence of each sample well was measured by using
a ﬂuorescent microplate reader (TECAN Saﬁre
2). Fluores-
cence of each sample well was normalized to percent of both
LIVE (no C60 compounds or transfection mixtures treatment
condition) and DEAD (70% methanol treated) control cell
groups. These normalized fractions are deﬁned as the fraction
of live and dead cells, respectively, in each of the C60-treated
samples. Since GFP ﬂuorescence has excitation/emission
wavelengths of 470/515 nm, close to that of calcein AM,
there was a possibility that GFP ﬂuorescence could interfere
with the calcein AM (LIVE) measurement leading to
potential errors for those wells containing C60 vector/DNA
mixtures. Thus, a baseline ﬂuorescence intensity of each
sample well at 495/515 nm was obtained before the addition
of the live cell/dead cell dyes. This intensity was then
subtracted from the ﬁnal calcein AM detection intensity.
Dynamic Light Scattering. For the dynamic light scat-
tering (DLS) experiments, a standard solution with concen-
tration 10 µg/µL of each of the C60 vectors was prepared in
each of these solvents: HPLC grade water, 10 mM Tris/
EDTA solution, and serum-free DMEM. These solvents were
ﬁltered through a 0.22 µm syringe ﬁlter (Millpore, MILLEX-
GP) prior to use. The size of standard 100 nm polystyrene
beads in Tris/EDTA solution and in serum-free DMEM was
measured to conﬁrm that no discrepancies were detected with
the data acquisition system.
DLS measurements were conducted using a Wyatt Tech-
nologies Dawn EOS instrument equipped with a quasi-elastic
light scattering interface module (Wyatt QELS unit). The
scattering angle used for detection was 90° at a constant
temperature of 25 °C. A 30 mW GaAs laser at λ ) 690 nm
was used. Data analysis and size distribution computations
were performed using the vendor supplied software (Astra
V) and a multi-τ digital recorder (Wyatt QELS).
Statistics. Statistical analysis was performed between
groups for the live/dead assay and for ﬂow cytometry studies.
The results are reported as means ( standard deviation.
Groups were analyzed by ANOVA with signiﬁcance deﬁned
by a p-value < 0.05, and pairwise comparison was performed
using the Tukey test. The cytotoxicity studies had four
samples per group, and the transfection studies had three
samples per group.
Results and Discussion
Initial screening was performed on each of the six different
derivatized C60 samples, compounds I-VI (Figure 1). The
different C60-vector/DNA complexes were assembled at
various R values (0.42-42) and each analyzed for its ability
to affect transfection in NIH 3T3 cells under serum-free
conditions. Serum-free conditions were used in these studies
to ensure that derivatized nanomaterial/DNA complexes were
not compromised by serum lipids and/or proteins, and that
the DNA complexes were imported into the cells based on
the individual physical properties of the complexes them-
selves, without the potential aid of serum proteins acting as
carrier. The best transfection efﬁciencies were routinely
observed after allowing transfection mixtures to remain on
cells for 24 h (transfection time), then removing the
transfection mixtures and incubating cells for an additional
24 h (incubation time) in the presence of serum for maximal
gene expression to be detected. Unless otherwise noted, all
transfection efﬁciency data presented below were for cells
transfected for 24 h under serum-free conditions and
incubated for an additional 24 h in the presence of serum.
All C60-conjugated transfection mixtures showed the ability
to transfect cells with exogenous DNA with statistically
signiﬁcant differences relative to unconjugated DNA alone
(naked DNA) (Table 1). “Transfection efﬁciency” as reported
in Table 1 is deﬁned as the ratio of GFP-positive cells as
determined by ﬂuorescence under ﬂow cytometry per total
number of cells counted in the ﬂow cytometer. No statistical
difference was observed between the transfection efﬁciencies
of the different groups at R ) 0.42 and R ) 4.2. For R values
above 4.2, compounds III and IV exhibited a statistical
difference in transfection efﬁciencies compared to the other
compounds. Both of these compounds exhibited an increased
transfection efﬁciency relative to the other C60 compounds
Table 1. Transfection Efﬁciencies of C60/DNA Transfection Mixtures at Various R Values Presented as a Quotient of
GFP-Fluorescent Cells Relative to the Total Number of Cells Analyzed as Measured by Flow Cytometry
a
transfection efﬁciency (%) at various R values
C60 vector R ) 0.42 R ) 4.2 R ) 8.4 R ) 16.8 R ) 42
IV 0.53 ( 0.13 0.42 ( 0.18 1.32 ( 0.57 31.33 ( 4.24 2.40 ( 0.13
III 0.43 ( 0.31 0.37 ( 0.21 0.99 ( 0.15 28.33 ( 4.94 1.86 ( 0.24
II 0.30 ( 0.20 0.58 ( 0.14 0.60 ( 0.13 0.32 ( 0.06 0.41 ( 0.17
I 0.27 ( 0.15 0.45 ( 0.28 0.62 ( 0.10 0.34 ( 0.04 0.43 ( 0.14
V 0.17 ( 0.12 0.36 ( 0.27 0.23 ( 0.10 0.11 ( 0.03 0.09 ( 0.05
VI 0.27 ( 0.21 0.15 ( 0.06 0.48 ( 0.25 0.10 ( 0.01 0.14 ( 0.04
naked DNA 0.01 ( 0.005
PEI (25 kDa) 28.7 ( 3.5
Cytopure 35.2 ( 5.1
a 10,000 events were counted for each sample. C60 vectors are listed in order of their measured efﬁciency at promoting transfection in
NIH 3T3 cells under serum-free conditions.
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R ) 16.8. At larger values of R the efﬁciency dropped off.
At R ) 16.8, their transfection efﬁciencies were comparable
to that of 25 kDa PEI containing and Cytopure transfection
reagent containing complexes. 25 kDa PEI is a widely used
and well-studied nonviral vector, while Cytopure is a
biodegradable polymeric transfection reagent that exhibits
very low cytotoxicity and is reported to work on a broad
spectrum of cell types, including hard-to-transfect primary
cell isolates.
To assess the transfection ability of C60 vectors in different
cell types, studies were also performed on two other cell
types: HEK 293 cells and MSCs. HEK 293 cells were chosen
since they are another standard cell line used routinely for
transfection assays, while MSCs were chosen due to their
eminence as primary cells for tissue engineering. Based on
the initial screening results of each of the various derivatized
C60 compounds for transfection-promoting ability in NIH 3T3
cells as reported in Tables 1 and 2, transfection studies were
also performed on HEK 293 cells and MSCs using com-
pounds III and IV at ratios of R ) 4.2 and R ) 16.8. Table
2 lists the transfection efﬁciencies obtained for such studies.
HEK 293 cells exhibited increased transfection efﬁciency
with an increase in R values. However, HEK 293 cells’
transfection efﬁciencies were lower than those observed for
NIH 3T3 cell at similar R values. MSCs exhibited low
transfection efﬁciencies overall, and no increase in trans-
fection efﬁciency was observed with increase in R values.
Transfected cells were visualized by ﬂuorescence microscopy
for morphological analysis after transfection (micrographs
not shown). Positive transfection of cells with the plasmid
coding for green ﬂuorescent protein could be easily discerned
by this technique. However, variations in transfection ef-
ﬁciency among the different cell types tested here is not
surprising, as cell type is a major factor in determining the
level of transfection and gene expression from nonviral
vectors as noted previously.
27 Differences in cell character-
istics, such as cell mitosis rates, can play an important role
in transgene expression, and may explain the differences in
the level of gene expression among the various cell lines
studied here.
28,29
Figures 2 a, b and c display the fraction of viable NIH
3T3 cells as a function of the C60 vector (no DNA present)
concentration after 2, 8, or 24 h post-treatment incubation
times, respectively. Incubation with C60 compounds for 2 h
resulted in a viable cell fraction greater than 50% for all C60
vector solutions. Lowest overall cell viability was observed
with compound I (0.55 ( 0.08) at 10 µg/µL, and no
statistically signiﬁcant increase in cell viability was observed
with decreasing compound I concentration. For all other C60
compounds tested, there was a general trend of increased
cell viability with decreased C60 compound concentration.
A tt h e8hC 60 incubation time, the fraction of live cells
was higher than 50% for all C60 solutions tested except those
exposed to compound I. For compound I, the cell viability
was the lowest (0.51 ( 0.04) at 10 µg/µL, but no statistically
signiﬁcant increase in cell viability was observed with
decreasing compound I concentration. For all other C60
vectors, there was a general trend of increased cell viability
with decreased compound concentration, but at each com-
pound concentration tested, the cell viability was lower in
the 8 h time point than in the corresponding sample
concentration at the 2 h time point.
At the 24 h C60 incubation time point, only cells treated
with compounds III and IV exhibited greater than 50% cell
viability at all concentrations tested, with an increase in cell
viability with decreased C60 compound (III and IV) con-
centration. All other compounds showed a general trend of
increased viability with a decrease in compound concentra-
tion, with cell viability values lower than 50% at 10 µg/µL.
Figures 3 a, b and c display the cell viability of NIH 3T3
cells cultured in the presence of the various C60-vector/DNA
mixtures as a function of both C60 compound concentration
and R values after 2, 8 or 24 h post-transfection time,
respectively. Cell viability at the two hour post-transfection
time point for compound I/DNA and compound II/DNA
mixtures increased from 0.19 ( 0.0 at 10 µg/µL( R ) 42)
to 0.70 ( 0.15 at 0.1 µg/µL( R ) 0.42). The fraction of live
cells was greater than 50% for all other C60 derivative/DNA
solutions at the 2 h post-transfection time point.
At the 8 h post-transfection time point, the fraction of live
cells for compound I/DNA and compound II/DNA was less
(27) Uchida, E.; Mizuguchi, H.; Ishii-Watabe, A.; Hayakawa, T.
Comparison of the Efﬁciency and Safety of Non-viral Vector-
Mediated Gene Transfer into a Wide Range of Human Cells. Biol.
Pharm. Bull. 2002, 25, 891–897.
(28) Mortimer, I.; Tam, P.; MacLachlan, I.; Graham, R. W.; Saravolac,
E. G.; Joshi, P. B. Cationic Lipid-Mediated Transfection of Cells
in Culture Requires Mitotic Activity. Gene Ther. 1999, 6, 403–
411.
(29) Brunner, S.; Sauer, T.; Carotta, S.; Cotten, M.; Saltik, M.; Wagner,
E. Cell Cycle Dependence of Gene Transfer by Lipoplex, Polyplex
and Recombinant Adenovirus. Gene Ther. 2000, 7, 401–407.
Table 2. Comparison of Transfection Efﬁciencies for
Octa-Amino C60 Compound III and Dodeca-Amino C60
Compound IV at R ) 4.2 and R ) 16.8 for NIH 3T3 Cells,
HEK 293 Cells and MSCs under Serum-Free Transfection
Conditions
a
transfection efﬁciencies (%)
cell line studied at
distinct R-values III/DNA IV/DNA
NIH 3T3 (R ) 4.2) 0.37 ( 0.21 0.42 ( 0.18
NIH 3T3 (R ) 16.8) 28.33 ( 4.94 31.33 ( 4.24
HEK 293 (R ) 4.2) 0.54 ( 0.08 0.60 ( 0.10
HEK 293 (R ) 16.8) 7.66 ( 0.22 10.05 ( 0.03
MSC (R ) 4.2) 0.09 ( 0.03 0.39 ( 0.03
MSC (R ) 16.8) 0.05 ( 0.01 0.07 ( 0.02
a Transfection efﬁciency values are presented as a quotient of
GFP (+) cells relative to the total viable cells present in the
transfected sample well as measured by ﬂow cytometry. [10,000
events were counted for each sample.]
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other samples, the trend was similar to that of the 2 h post-
transfection time point, with cell viability greater than 50%
and an increase in viability observed with a decrease in
transfection mixture concentration.
At the 24 h time point, cells treated with the compound
V/DNA mixture exhibited greater than 50% cell viability at
all concentrations tested, while compound I/DNA, compound
II/DNA exhibited less than 50% cell viability. Cells treated
with compounds III/DNA, IV/DNA and VI/DNA mixtures
resulted in cell viabilities less than 50% at 4 µg/µL( R )
16.8) and 10 µg/µL( R ) 42), but greater than 50% viability
when added at lower concentrations.
DLS and optical microscopy studies were performed to
help elucidate the biophysical structure/activity relationships
that might exist between the various C60 complexes. These
studies were carried out to help generate correlations between
the different C60 vectors, and the various C60 vector/DNA
structural attributes resulting in the different transfection
efﬁciencies and cytotoxicity results observed under serum-
free conditions. Table 3 presents the DLS measurements on
the various C60 vector compounds I-VI when dissolved
Figure 2. Fraction of live NIH 3T3 cells after incubation
with the different C60 vectors as a function of derivatized
fullerene concentration after (a) 2 h, (b) 8 h, or (c) 24 h
C60-incubation times respectively, under serum-free condi-
tions. Error bars represent mean ( standard deviation
for n ) 4.
Figure 3. Fraction of live NIH 3T3 cells after incubation
with the different C60/DNA transfection mixtures as a
function of C60 compound concentration and varying R
value after (a) 2 h, (b) 8 h, or (c) 24 h post-transfection
incubation time, under serum-free conditions respectively.
Error bars represent the mean ( standard deviation for n
) 4.
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solution (4 µg/µL), in serum-free DMEM (4 µg/µL), or when
dissolved in complex with DNA in 10 mM Tris/EDTA (4
µg/µL, R ) 16.8) or as a complex with DNA in serum-free
DMEM (4 µg/µL, R ) 16.8). The concentration of 4 µg/µL
was chosen for DLS experiments since compounds III and
IV exhibited maximum transfection efﬁciency at this con-
centration of C60. The Rh values in Table 3 provide
qualitative information about the transfection mixture ag-
gregate behavior which can readily be seen in Figures 4 and
5. The Rh parameter obtained from the DLS measurements,
and shown in Table 3, corresponds to the radius of a
monodisperse hypothetical sphere having the same diffusion
constant as that of the C60 compound aggregates or the C60/
DNA mixture aggregates under study. The polydispersity
index (PDI) provides a metric for describing the size
distribution. PDI values between 0 and 0.05 indicate more
monodisperse particles, and values above 0.05 indicate
broadened size distributions.
30 Clearly, the Rh values shown
in Table 3 for the various C60 compounds and C60/DNA
complexes are average values for quite polydisperse popula-
tions of aggregates. Previous work by our group and others
using atomic force microscopy (AFM) and cryo transmission
electron microscopy (cryo-TEM) have shown that derivatized
C60 compounds form aggregates that are irregularly shaped
in solution.
31,32 The Rh values observed for these C60
compounds and the C60/DNA mixtures suggests that these
reagents also form such irregularly shaped aggregates when
in aqueous solutions, including when dissolved in solutions
of physiological ionic strength such as DMEM. Such
qualitative information about the aggregate behavior provides
valuable information for understanding the transfection and
toxicity results, as discussed below.
All C60 compounds display a broadly distributed aggregate
size in each solvent tested (water, 10 mM Tris/EDTA
solution, and serum-free DMEM). The compounds had
aggregate sizes between 47 and 650 nm (PDI ) 0.33-0.51)
and between 33 and 446 nm (PDI ) 0.29-0.46) in plain
water and 10 mM Tris/EDTA solution, respectively. In the
presence of DNA, there is an increase in Rh for all
formulations. In general, the Rh values decrease in the order
V, VI > I > II > III, IV in the presence of DNA.
Presumably, this trend is the result of the inﬂuence of the
various structures of the C60 derivatives on the condensation
behavior of the DNA in the transfection mixture. In the case
of cationic polymers, the condensation process with DNA
has been thought to rely predominantly on electrostatic
interactions with minor contributions from other interactions
such as hydrophobic interactions, hydrogen bonding, and van
der Waals forces.
5 In case of the positively charged C60
derivatives, the hydrophobicity of the C60 core, and electro-
static interactions between the water-soluble functional
groups and the DNA are the main contributors to the
condensation process.
8,14,16 Compound I, with two adducts
on the fullerene core, has less positive charge than the hexa-
amino C60 adduct of compound II and the octa-amino adduct
of compound III. Fewer electrostatic interactions between
functionalized C60 vectors and the DNA sugar-phosphate
backbone can lead to a decrease in condensation capacity,
resulting in larger C60-vector/DNA complexes. Compound
V, although polar, has no net charge at neutral pH; while
compound VI will possess a negative charge, the same as
that of DNA. Thus, for compounds V and VI, hydrophobicity
is presumably the only interaction contributing to the
formation of the DNA condensates, and this interaction
appears insufﬁcient to fully condense the DNA, leading to
large C60 vector/DNA complex aggregates.
The relatively large sizes for the C60 vector/DNA complexes,
and in particularly for those formed from compounds I, II, V
and VI, may be a reason for the poor transfection efﬁciencies
observed with these compounds. This may also be a reason for
the low transfection efﬁciency reported for a similar positively
charged amino-C60 compound with a monoadduct on the
fullerene core.
17 However, increased positive charge-state alone
is insufﬁcient to solely predict increased transfection capability
of amino-derivatized fullerenes. Variation in transfection pro-
tocol and/or cell types can also dramatically affect transfection
efﬁciencies, as positively charged amino-derivatized C60 similar
to compound IV have previously been shown to be inefﬁcient
at effecting transfection.
17 In general, the condensation behavior
(30) Pecora, R. Dynamic Light Scattering; Plenum: New York, 1985.
(31) Isobe, H.; Sugiyama, S.; Fukui, K.-i.; Iwasawa, Y.; Nakamura, a.
E. Atomic Force Microscope Studies on Condensation of Plasmid
DNA with Functionalized Fullerenes. Angew. Chem., Int. Ed.
2001, 40, 3364–3367.
(32) Sitharaman, B.; Asokan, S.; Rusakova, I.; Wong, M. S.; Wilson,
L. J. Nanoscale Aggregation Properties of Neuroprotective Car-
boxyfullerene (C3) in Aqueous Solution. Nano Lett. 2004, 4,
1759–1762.
Table 3. Hydrodynamic Radius (Rh) of the Different C60 Derivatives in Water (4 µg/µL), 10 mM Tris/EDTA Solution
(4 µg/µL), Serum-Free DMEM (4 µg/µL), in Complex with DNA in 10 mM Tris/EDTA Solution (4 µg/µL, R ) 16.8), and in
Complex with DNA in Serum-Free DMEM (4 µg/µL, R ) 16.8)
IV III II I V VI
solutions Rh (nm) PDI Rh (nm) PDI Rh (nm) PDI Rh (nm) PDI Rh (nm) PDI Rh (nm) PDI
water 50 0.43 47 0.51 126 0.33 650 0.55 90 0.39 72 0.37
Tris EDTA 35 0.33 33 0.40 83 0.29 446 0.46 51 0.42 58 0.22
serum-free DMEM 29 0.26 34 0.28 61 0.31 150 0.24 47 0.45 20 0.33
in complex with DNA [Tris/EDTA] 125 0.24 146 0.31 366 0.43 503 0.52 803 0.33 834 0.55
in complex with DNA [serum-free DMEM] 111 0.36 163 0.44 440 0.34 485 0.42 721 0.22 803 0.41
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factors including the molecular weight of the DNA condensing
agent, the density of the charges on the condensing agent, and
the ratio of composition (R values) between the condensing
vector and the DNA.
5 In addition, it is now well-documented
that the size of the transfection vector/DNA complex is one of
the most important parameters for efﬁcient DNA delivery into
cells, with the most efﬁcient uptake observed for complex with
sizes <150-200 nm in diameter.
5 The Rh values shown in
Table 3 suggest that only DNA complexes formed with
compounds III and IV satisfy these criteria.
On addition of the C60-vector/DNA complexes to cells,
the complexes formed with compounds I and II immediately
aggregated further to form large clusters, even at the lowest
Figure 4. Representative morphologies of NIH 3T3 cells and the C60/DNA complexes at R ) 0.42 ten minutes after
transfection. The optical images represent complexes formed with compound (a) I, (b) II, (c) III, (d) IV, (e) V, and (f)
VI. All images are shown at the same magniﬁcation.
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microscopy images of all C60-vector/DNA complexes at R
) 0.42 ten min after their addition to NIH 3T3 cells. Large,
irregularly shaped aggregates (shown as brown) can clearly
be seen for complexes formed with compound I (Figure 4a)
and for complexes formed with compound II (Figure 4b).
The aggregate concentration is greater and more densely
distributed for compound I than for compound II. No such
increased aggregation propensity was seen for the other C60
vector/DNA complexes (Figure 4c-f). However, time-
dependence of aggregation could be observed for compound
III and compound VI. Figure 5a,b shows the optical
microscopy images of compound III/DNA, and compound
VI/DNA complexes at R ) 0.42 at 24 h post-transfection
time. The images show the presence of large sized ag-
gregates, more densly distributed for compound VI than for
compound III.
Interestingly, addition of compound III/DNA mixtures
caused cell morphological changes when added to cultured
cells, causing the attached cells to round up from the
substratum surface in contrast to the usual planar, extended/
elongated shapes the cells assumed in the normal growth
state. Figure 4c gives the best visual representation of this
effect. This shape change may be attributed to the depolym-
erization/disruption of either the actin or tubulin networks
of the cytoskeleton by the complexes, and/or to the disrup-
tion/inhibition of focal adhesion plaques formed on the cell
surface. However, this observation at R ) 0.42 does not have
any noticeable effects on cell proliferation, as ﬂow cytometry
measurements indicate no statistically signiﬁcant difference
in the number of cells for those treated with compound III/
DNA complexes relative to the controls cells (no C60/DNA
complexes added).
Our results indicate that compounds III and IV, when
complexed with DNA, bring about the highest levels of
transfection when compared to the other derivatized C60
compounds under evaluation in this study. At the optimal
ratio of compound III or IV to DNA (R ) 16.8), ap-
proximately 30% of cells are expressing GFP at 24 h post-
transfection time. However, at 24 h post-transfection, there
is only approximately 30% viability in cells treated with these
two tranfection mixtures. This result is in contrast to cell
viability of greater than 50% in cells treated with the
compounds III or IV alone at equivalent C60 concentrations
(4µg/µL) as that when in complex with DNA at R ) 16.8.
The temporal increase in aggregate sizes for these C60/DNA
complexes (not seen in the free C60 compounds alone) leads
to precipitation onto the cell surface when these mixtures
are left in the culture medium for 24 h (e.g., see Figure 5).
This effect may explain the higher levels of cell death in
the transfection mixture-treated cells.
The overall trend observed in these studies was that
increased cell death was observed with an increase in either
C60 concentration alone or for increased R values in C60/
DNA mixtures, irrespective of the chemical nature of the
C60 compound, with compounds III and IV exhibiting the
least toxicity when free in solution, but not necessarily when
complexed with DNA (under these conditions, compound
V seems to exhibit the least cell toxicity). Also, higher levels
of cytotoxicity seem to correlate more with complex ag-
gregate formation induced by the presence of DNA in the
mixtures, leading to the formation of visible precipitates.
Such deposition of aggregates onto the cell surface will
impair normal functioning of the plasma membrane and
thereby contribute to cell death.
31 There may also be other
slow processes contributing to cell death for the positively
charged C60 vectors in the C60/DNA solutions at the longer
(8 and 24 h) transfection times. Following cellular entry, the
presence of positively charged amino-C60 compounds (I-IV)
(individuals or as aggregates) inside the cell or nucleus may
lead to disruptions to other cellular functions, such as
interfering with histone-DNA interactions and/or other
cellular processes.
7
The favorable transfection efﬁciencies of compounds III
and IV suggest that these compounds have some character-
istics in common with other positively charged amino-C60
derivatives previously cited in the literature which are
Figure 5. Representative optical microscopy images of
NIH 3T3 cells incubated with C60/DNA complexes
formed using compounds (a) III and (b) VI at R ) 0.42
twenty four hours post-transfection. All images are
shown at the same magniﬁcation.
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include having a ﬂexible linker situated between the fullerene
core and the positively charged amino groups.
14,16 Although
the results presented here suggest that the structures of
compounds III and IV will result in higher levels of
transfection than those previously reported by others, direct
comparison of our results with the results from others using
different structurally derivatized positively charged amino
C60 vectors is not possible, since the structure of the C60
vectors, the cell lines tested, and the methodologies used are
not consistent.
Another distinct feature of all the C60 vectors reported here
is their water solubility which obviates the need to use
organic solvents such as dimethylformamide (DMF) in the
preparation of the transfection mixture; the high cytotoxicity
observed for some other C60-based transfection agents has
been attributed to the toxicity of DMF.
14,16
The comparable transfection efﬁciencies of compounds III
and IV on NIH 3T3 cells to those of commercially available
nonviral vectors 25 kDa PEI and Cytopure is encouraging.
25 kDa PEI is a widely used nonviral vector and is quite
often used as a standard for comparing new nonviral
vectors.
33,34 However, it has also been associated with high
cytotoxicity. This high cytotoxicity has been attributed more
to free PEI than to the PEI/DNA complex. However, in case
of compound III or IV, at the optimal R ) 16.8, their
complexes with DNA show higher toxicity (30% viability)
compared to the free compounds III or IV alone (greater
than 50% cell viability). Since the cytotoxicity seems to
correlate more with complex aggregate formation induced
by the presence of DNA in the mixtures, future reﬁnement
of the C60/DNA complex preparation protocol, such as
disaggregating these complexes with phosphate buffer and/
or NaCl, should potentially lead to lower cytotoxicity while
maintaining the same level of transfection efﬁciency, or
potentially even increase these transfection efﬁciency levels.
Furthermore, although not addressed in this study (for reasons
of maintaining uniformity in C60/DNA complex formation
and cellular entry), the presence of serum proteins on
enhanced C60/DNA complex uptake, and on subsequent cell
viability during extended transfection times, would also be
worth examining, and could be expected to lower the
observed cellular cytotoxicity levels seen in this study.
The small, but statistically signiﬁcant, expression of the
reporter protein from C60/DNA conjugates formed from
compounds V and VI was surprising and interesting since
these samples do not possess a net positive charge under
the physiological conditions used to form the complexes,
although there have been limited reports of other nonpositive
charged nanoparticles translocating into cells
35 and, indeed,
also demonstrating gene transfection.
36 Thus, at least for
some derivatized C60 molecules, the hydrophobic nature of
the C60 carbon nanostructures may be the common important
property in their binding to DNA and their subsequent
translocation into the interior of the cell. There is now a
growing body of work that suggests that carbon nanomate-
rials such as fullerenes, metallofullerenes and carbon nano-
tubes, due the hydrophobicity of their carbon sheaths, have
the ability to efﬁciently translocate into the interior of cells
irrespective of the charge of their water-solubilizing
moieties.
8,9,37–41 In addition, carbon nanomaterials such as
Gd@C60, Gd@C82, Gd@C80 and Gd@ultrashort single-
walled carbon nanotubes (Gd@US-tubes) have shown po-
tential as high-performance magnetic resonance imaging
(MRI) contrast agents
38,39,42–48 suitable for advanced ap-
plications such as tracking and/or delivery of magnetically
labeled cells by MRI in ViVo. These reports, along with the
favorable C60-based gene transfection results reported here
(33) Godbey, W. T.; Wu, K. K.; Mikos, A. G. Poly(ethylenimine) and
Its Role in Gene Delivery. J. Controlled Release 1999, 60, 149–
160.
(34) Dong, W.; Li, S.; Jin, G.; Sun, Q.; Ma, D.; Hua, Z. Efﬁcient Gene
Transfection into Mammalian Cells Mediated by Cross-linked
Polyethylenimine. Int. J. Mol. Sci. 2007, 8, 81–102.
(35) Wilhem, C.; Billotey, C.; Roger, J.; Pons, J. N.; Bacri, J. C.;
Gazeau, F. Intracellular Uptake of Anionic Superparamagnetic
Nanoparticles as a Function of Their Surface Coating. Biomaterials
2003, 24, 1001–1011.
(36) Roy, I.; Ohulchanskyy, T. Y.; Bharali, D. J.; Pudavar, H. E.;
Mistretta, R. A.; Kaur, N.; Prasad, P. N. Optical Tracking of
Organically Modiﬁed Silica Nanoparticles as DNA Carriers: A
Nonviral, Nanomedicine Approach for Gene Delivery. Proc. Natl.
Acad. Sci. U.S.A. 2005, 102, 279–284.
(37) Ashcroft, J. M.; Tsyboulski, D. A.; Hartman, K. B.; Zakharian,
T. Y.; Marks, J. W.; Weisman, R. B.; Rosenblum, M. G.; Wilson,
L. J. Fullerene (C60) Immunoconjugates: Interaction of Water-
Soluble C60 Derivatives with the Murine Anti-gp240 Melanoma
Antibody. Chem. Commun. 2006, 3004–3006.
(38) Anderson, S. A.; Lee, K. K.; Frank, J. A. Gadolinium-Fullerenol
as a Paramagnetic Contrast Agent for Cellular Imaging. InVest.
Radiol. 2006, 41, 332–338.
(39) Sitharaman, B.; Tran, L. A.; Bolskar, R. D.; Muthupillai, R.;
Flamm, S. D.; Mikos, A. G.; Wilson, L. J. Gadofullerenes as
Nanoscale Magnetic Labels for Cellular Magnetic Resonance
Imaging. Contrast Media Mol. Imaging 2007, 2, 139–146.
(40) Pantarotto, D.; Briand, J.-P.; Prato, M.; Bianco, A. Translocation
of Bioactive Peptides Across Cell Membranes by Carbon Nano-
tubes. Chem. Commun. 2004, 1 (1), 16–17.
(41) Kam, N. W. S.; Jessop, T. C.; Wender, P. A.; Dai, H. Nanotube
Molecular Transporters: Internalization of Carbon Nanotube-
Protein Conjugates into Mammalian Cells. J. Am. Chem. Soc.
2004, 126 (22), 6850–6851.
(42) Stevenson, S.; Rice, G.; Glass, T.; Harlch, K.; Cromer, F.; Jordan,
M. R.; Craft, J.; Hadju, E.; Bible, R.; Olmstead, M. M.; Maltra,
K.; Fisher, A. J.; Balch, A. L.; Dorn, H. C. Small-Bandgap
Endohedral Metallofullerenes in High Yield and Purity. Nature
1999, 401 (6748), 55–57.
(43) Bolskar, R. D.; Benedetto, A. F.; Husebo, L. O.; Price, R. E.;
Jackson, E. F.; Wallace, S.; Wilson, L. J.; Alford, J. M. First
Soluble M@C60 Derivatives Provide Enhanced Access to Met-
allofullerenes and Permit in Vivo Evaluation of
Gd@C60[C(COOH)2]10 as a MRI Contrast Agent. J. Am. Chem.
Soc. 2003, 125 (18), 5471–5478.
(44) Toth, E.; Bolskar, R. D.; Borel, A.; Gonzalez, G.; Helm, L.;
Merbach, A. E.; Sitharaman, B.; Wilson, L. J. Water-Soluble
Gadofullerenes: Toward High-Relaxivity, pH-Responsive MRI
Contrast Agents. J. Am. Chem. Soc. 2005, 127 (2), 799–805.
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8,14–16 offer opportunities for development of
analogous Gd@C60-based vectors to monitor noninvasively
the biodistribution and pharmacokinetics of gene therapy
vectors in ViVo.
49
Conclusion
A new class of water-soluble C60 transfecting agents with
positively charged, negatively charged, or neutral chemical
functionalities under physiological conditions was prepared
using Hirsch-Bingel chemistry. Transfection, cytotoxicity
and biophysical structure/activity studies were performed in
an effort to elucidate the relationship between the hydro-
phobicity of the fullerene core, the hydrophilicity of the
water-solubilizing groups, and the overall charge state of the
C60 vectors in gene delivery/expression. All C60 derivatives
showed statistically signiﬁcant transfection efﬁciency com-
pared to naked DNA. However, only two positively charged
C60 derivatives, namely, an octa-amino derivatized C60 and
a dodeca-amino derivatized C60 vector, showed efﬁcient in
Vitro transfection. All C60 vectors showed an increase in
toxicity in a dose-dependent manner. Increased levels of
cellular toxicity were observed for positively charged C60
vectors relative to the negatively charged and neutral vectors.
Structural analyses using dynamic light scattering and optical
microscopy conﬁrmed that higher positive charge on C60
compounds is a dominant physical attribute necessary for
optimal C60/DNA structural features leading to increased
transfection efﬁciency, and that aggregation is the major
factor that negatively affected the cytotoxicity proﬁles of the
C60 vector/DNA complexes. Aggregation is presumably also
the dominant reason for increased cytotoxicity of certain
speciﬁc derivatized C60 compounds (most notable for com-
pound I) even in the absence of DNA, at least when analyzed
under the serum-free conditions utilized in this study. Future
studies should be able to capitalize on this information and
enable the design of additional C60 derivatives that address
these issues speciﬁcally and help lower the propensity of
these reagents to aggregate in the presence of DNA. Such
reagents would be expected to enhance transfection of cells
and tissues while simultaneously lowering toxicity levels.
Future studies using these reagents will also more precisely
indicate the cellular uptake and endosomal release mecha-
nisms that these compounds inherently possess, thereby
lending further insight into potential enhanced chemical
design of future generations of these carbon-based nanoma-
terials speciﬁcally for DNA delivery into the cell nucleus.
The successful demonstration of intracellular DNA uptake,
intracellular transport, and gene expression from DNA using
C60 vectors suggests the possibility of developing analogous
Gd@C60-based vectors to serve simultaneously as both
therapeutic and diagnostic agents.
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